Blog
Digital Therapeutics and Their Impact on Future Diabetes Treatment
This American Diabetes Alert Day, learn how digital therapeutics can improve diabetes awareness, prevention, access to screenings, and better…
All Results
Blog
Blog
Bleeding Disorders: A Focus on Hemophilia and von Willebrand Disease
More than three million Americans are living with bleeding disorders. These disorders—including hemophilia, von Willebrand disease, and other rare…
Blog
What does the Future Hold for Stomach, Lung, and Testicular Cancer Treatments?
Cancer is a leading cause of death worldwide. Despite the lack of a definitive cure for cancer, there are many types of cancer treatments. A…
Blog
Ask the Experts: How is the Medical Industry Currently Addressing Sickle Cell Disease?
Sickle Cell Disease (SCD) is a disease with few curative treatments that affects people globally. Both young and older patients who struggle with SCD…
Blog
World Blood Donor Day 2020: Why is Donating Blood Important, Especially During a Pandemic?
To mark World Blood Donor Day, we interviewed two members of our PRA family who have gone above and beyond for Red Cross efforts. We discussed why…
Blog
ASH 2019 – Insights from our experts from the 61st American Society of Hematology (ASH) meeting
The American Society of Hematology (ASH) 2019 meeting, the world’s biggest hematology conference, addressed a number of new and exciting…
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 1
As the oncology environment continues to grow towards more targeted therapies, it is imperative that patient recruitment strategies focus on how to…
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 2
This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia…
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
Fact Sheet
Oncology & Hematology Fact Sheet
As a recognized leader in conducting complex, global oncology/hematology trials, PRA has contributed to the approval of 16 important drugs. During…